AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 165 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $120,000 | +50.0% | 10,428 | +29.9% | 0.00% | +50.0% |
| Q2 2019 | $80,000 | +2.6% | 8,030 | +32.2% | 0.00% | 0.0% |
| Q1 2019 | $78,000 | -15.2% | 6,072 | 0.0% | 0.00% | -33.3% |
| Q4 2018 | $92,000 | -24.6% | 6,072 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $122,000 | +3.4% | 6,072 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $118,000 | -3.3% | 6,072 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $122,000 | +74.3% | 6,072 | +15.0% | 0.00% | +50.0% |
| Q4 2017 | $70,000 | -7.9% | 5,280 | +29.0% | 0.00% | 0.0% |
| Q3 2017 | $76,000 | +38.2% | 4,092 | +37.8% | 0.00% | 0.0% |
| Q2 2017 | $55,000 | +71.9% | 2,970 | +107.7% | 0.00% | +100.0% |
| Q1 2017 | $32,000 | -31.9% | 1,430 | +4.8% | 0.00% | -50.0% |
| Q4 2016 | $47,000 | – | 1,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
| Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
| Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
| Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
| Fondren Management LP | 35,000 | $404,000 | 0.34% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
| BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
| Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
| FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
| Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |